Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures

Nephrol Dial Transplant. 2014 Aug;29(8):1450-2. doi: 10.1093/ndt/gfu086. Epub 2014 Apr 15.

Authors

Wei Ling Lau¹, Kamyar Kalantar-Zadeh²

Affiliations

¹ Division of Nephrology and Hypertension, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine (UCI) School of Medicine, Orange, CA, USA.
² Division of Nephrology and Hypertension, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine (UCI) School of Medicine, Orange, CA, USA Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Alkaline Phosphatase / pharmacokinetics
Alkaline Phosphatase / therapeutic use*
Bone Density
Bone Diseases, Metabolic / drug therapy*
Bone Diseases, Metabolic / etiology
Bone Diseases, Metabolic / mortality
Global Health
Hip Fractures / drug therapy*
Hip Fractures / etiology
Hip Fractures / mortality
Humans
Renal Insufficiency, Chronic / complications*
Renal Insufficiency, Chronic / enzymology
Renal Insufficiency, Chronic / mortality
Survival Rate / trends

Substances

Alkaline Phosphatase

Grants and funding